Recombinant Bifidobacterium longum subsp. infantis Methionyl-tRNA formyltransferase (fmt)

Shipped with Ice Packs
In Stock

Product Specs

Form
Lyophilized powder. We will preferentially ship the available format, but please note any special format requirements when ordering, and we will try to accommodate your request.
Lead Time
Delivery times vary depending on the purchase method and location. Please consult your local distributor for specific delivery information. All proteins are shipped with standard blue ice packs. Please contact us in advance if you require dry ice shipping, as additional charges will apply.
Notes
Avoid repeated freeze-thaw cycles. Working aliquots can be stored at 4°C for up to one week.
Reconstitution
Briefly centrifuge the vial before opening to collect contents at the bottom. Reconstitute the protein in sterile deionized water to a concentration of 0.1-1.0 mg/mL. We recommend adding 5-50% glycerol (final concentration) and aliquoting for long-term storage at -20°C/-80°C. Our default final glycerol concentration is 50% for your reference.
Shelf Life
Shelf life depends on several factors, including storage conditions, buffer components, storage temperature, and protein stability. Generally, the liquid form has a shelf life of 6 months at -20°C/-80°C, while the lyophilized form has a shelf life of 12 months at -20°C/-80°C.
Storage Condition
Store at -20°C/-80°C upon receiving. Aliquot for multiple uses. Avoid repeated freeze-thaw cycles.
Tag Info
The tag type is determined during the manufacturing process. If you require a specific tag type, please inform us, and we will prioritize developing it.
Synonyms
fmt; Blon_2133; BLIJ_2210Methionyl-tRNA formyltransferase; EC 2.1.2.9
Buffer Before Lyophilization
Tris/PBS-based buffer, 6% Trehalose.
Datasheet
Please contact us to get it.
Expression Region
1-328
Protein Length
full length protein
Purity
>85% (SDS-PAGE)
Species
Bifidobacterium longum subsp. infantis (strain ATCC 15697 / DSM 20088 / JCM 1222 / NCTC 11817 / S12)
Target Names
fmt
Target Protein Sequence
MLKLVFAGTP DVAVPSLKAF ATDPRFDVVG VITRPDAPTG RGRKLTPSPV KAKALELGLP VIDLKPRSPE FMEALNDLHA DIAAVIAYGN ILPKNVLDAV PMGWYNLHFS NLPKWRGAAP AQRAIWAGDP TTGADVFKVG EGLDDGPIVA SLTIELTGRE TSGELLDRLA EEGAPMYVDA LAAVGEGTAT FTAQPAECLE YAHKITVEDA RISWTDEAGA IDRQIRACTP HPGAWTELFA EGPIADNDGS TAKSLTLHIL AAQPADQSNP NTPADLKPGE LKVGKKNVWV GTGSTPLELI QVKAQGKKAM RAADWARGAR LSPAACVR
Uniprot No.

Target Background

Function
Adds a formyl group to the free amino group of methionyl-tRNA(fMet). This formyl group plays a crucial role in the initiator function of N-formylmethionyl-tRNA by facilitating its recognition by IF2 and preventing its use by the elongation machinery.
Database Links
Protein Families
Fmt family

Q&A

What is Methionyl-tRNA formyltransferase (fmt) in B. infantis and what is its functional significance?

Methionyl-tRNA formyltransferase (fmt) in B. infantis is an essential enzyme responsible for formylating methionyl-tRNA to generate formylmethionyl-tRNA (fMet-tRNA), which serves as the initiator tRNA for protein synthesis in bacteria. This enzyme plays a critical role in translation initiation by adding a formyl group to the amino group of methionine attached to the initiator tRNA.

The functional significance of fmt extends beyond basic protein synthesis. In B. infantis, which has evolved specialized metabolic pathways for human milk oligosaccharide (HMO) utilization, efficient protein synthesis is critical for expressing the extensive array of enzymes required for HMO metabolism . The genome of B. infantis contains specialized genes for binding, internalizing, and metabolizing HMOs, all requiring proper translation initiation mediated by fmt.

Methodology for studying fmt function typically includes:

  • Comparative genomics across Bifidobacterium species

  • Gene expression analysis during growth on different substrates

  • Recombinant protein expression and purification

  • In vitro enzymatic assays measuring formylation activity

How can researchers clone and express recombinant B. infantis fmt for structural and functional studies?

The recommended methodology for cloning and expressing recombinant B. infantis fmt involves:

Step 1: Gene Amplification

  • Extract genomic DNA from B. infantis cultures (preferably strain ATCC 15697 as the reference strain)

  • Design primers targeting the fmt gene (Blon_XXXX) with appropriate restriction sites

  • Amplify using high-fidelity PCR with optimized conditions for GC-rich Bifidobacterium DNA

Step 2: Expression Vector Construction

  • Clone the amplified fmt gene into a suitable expression vector (pET series for E. coli)

  • Include a purification tag (His6, GST) for downstream purification

  • Confirm sequence integrity through DNA sequencing

Step 3: Heterologous Expression

  • Transform expression construct into E. coli BL21(DE3) or similar expression strains

  • Optimize expression conditions: temperature (16-30°C), IPTG concentration (0.1-1.0 mM), and induction time (4-16 hours)

  • Consider codon optimization to account for different codon usage between B. infantis and E. coli

Step 4: Protein Purification

  • Lyse cells using methods that preserve enzyme activity (gentle sonication in buffer with protease inhibitors)

  • Purify using affinity chromatography based on the chosen tag

  • Further purify via size exclusion chromatography if needed

Notable challenge: B. infantis fmt may require specific conditions to maintain solubility and activity, as seen with other enzymes involved in B. infantis specialized metabolic pathways .

What are the optimal conditions for recombinant B. infantis fmt enzymatic activity?

Based on studies of fmt enzymes from related bacterial species and the specific growth conditions of B. infantis, the following parameters are likely optimal for enzymatic activity:

ParameterOptimal RangeNotes
pH6.5-7.5Reflecting the slightly acidic environment of the infant gut
Temperature37°CCorresponding to human body temperature
Cofactors10-formyltetrahydrofolateEssential donor of formyl group
Divalent ionsMg²⁺ (2-5 mM)Required for optimal activity
Reducing agentsDTT or β-mercaptoethanolTo maintain thiol groups in reduced state
SubstrateMet-tRNAᴹᵉᵗGenerated in vitro using purified tRNAᴹᵉᵗ and methionyl-tRNA synthetase

Methodology for activity assessment:

  • Spectrophotometric assays measuring the decrease in 10-formyltetrahydrofolate absorbance

  • Radioactive assays using [¹⁴C]-labeled formyl groups

  • HPLC analysis of formylated versus unformylated Met-tRNAᴹᵉᵗ

The enzymatic activity of B. infantis fmt may be particularly adapted to function efficiently in the lower pH environment created by B. infantis metabolic activities, which produce lactate and acetate that lower intestinal pH to approximately 5.15 in colonized infants .

How might fmt activity relate to B. infantis' specialized nitrogen metabolism?

Recent research has revealed that B. infantis possesses unique nitrogen metabolism capabilities, particularly its ability to utilize human milk urea as a nitrogen source . The fmt enzyme likely plays a critical regulatory role in this specialized metabolism through several mechanisms:

  • Differential translation regulation: Fmt-mediated initiation may preferentially enhance the translation of enzymes involved in nitrogen assimilation pathways during growth on urea.

  • Nitrogen resource allocation: During growth on urea, B. infantis demonstrates significant metabolic reprogramming, with 234 proteins incorporating ¹⁵N-labeled nitrogen from urea . Fmt activity may regulate which proteins receive priority for the limited nitrogen resources.

  • Connection to urease expression: The urease gene cluster (essential for urea utilization) may be regulated at the translational level through fmt-dependent mechanisms.

Experimental approach to study this relationship:

  • Compare fmt activity and expression levels when B. infantis is grown on different nitrogen sources (urea vs. complex nitrogen)

  • Analyze translational efficiency of nitrogen metabolism genes in wild-type vs. fmt-depleted strains

  • Perform ribosome profiling to identify differentially translated mRNAs dependent on fmt activity

  • Use metabolic flux analysis with labeled nitrogen to track the impact of fmt modulation

The transcriptional program induced by urea nitrogen metabolism in B. infantis likely requires precise translational control, making fmt activity a potential regulatory node in this specialized metabolic network.

What is the relationship between fmt function and B. infantis colonization efficiency in the infant gut?

B. infantis is uniquely adapted to colonize the infant gut, with specific strains like EVC001 constituting up to 80% of the total microbiota in breastfed infants . The fmt enzyme may play several critical roles in this colonization efficiency:

  • Rapid protein synthesis during colonization: Fmt-mediated efficient translation initiation likely enables the rapid protein synthesis required during the critical colonization window in the first month of life.

  • Expression of HMO utilization machinery: B. infantis outcompetes other bacteria through its efficient HMO metabolism, which depends on the expression of numerous specialized enzymes (glycosidases, transporters) . Fmt function ensures these proteins are rapidly and efficiently synthesized.

  • Adaptation to nitrogen limitation: The infant gut can be a nitrogen-limited environment, and fmt may help prioritize translation of essential proteins during nitrogen stress.

Methodological approaches to investigate this relationship:

  • Develop conditional fmt mutants in B. infantis using inducible systems

  • Compare colonization efficiency in gnotobiotic mouse models

  • Measure competitive fitness against other gut bacteria with wild-type vs. fmt-depleted strains

  • Analyze proteome composition during colonization using quantitative proteomics

Table: Colonization Efficiency Comparison of B. infantis Strains with Varying fmt Expression Levels

Strain CharacteristicsRelative Colonization (%)HMO Utilization EfficiencyCompetitive IndexKey Proteins Affected
Wild-type fmt100+++1.0Reference baseline
fmt overexpression110-130++++1.2-1.5Enhanced ABC transporters, glycosidases
fmt depletion (20%)40-60+0.3-0.5Reduced transport systems, metabolic enzymes
fmt depletion (80%)<10+/-<0.1Global protein synthesis defect

Note: This table represents predicted outcomes based on current understanding of fmt function and B. infantis metabolism.

How does fmt function potentially impact B. infantis' immunomodulatory properties?

B. infantis demonstrates significant immunomodulatory effects, including enhancing the synthesis of IL-10 (an anti-inflammatory cytokine) by T regulatory cells . The fmt enzyme may influence these immunomodulatory properties through:

  • Regulation of surface protein expression: Bacterial surface proteins that interact with host immune cells require efficient translation, which depends on fmt activity.

  • Production of immunomodulatory metabolites: B. infantis produces metabolites that influence host immunity, including short-chain fatty acids (SCFAs). The enzymes involved in these metabolic pathways require fmt-mediated translation.

  • Stress response during immune challenge: When exposed to host immune factors, B. infantis must rapidly adapt its proteome, a process dependent on efficient translation initiation.

Experimental approaches to investigate this relationship:

  • Compare cytokine profiles induced by wild-type vs. fmt-modulated B. infantis strains

  • Analyze surface proteome changes resulting from altered fmt activity

  • Measure SCFA production with varying levels of fmt expression

  • Assess bacterial survival under immune stress conditions with different fmt activity levels

B. infantis has demonstrated the ability to reduce DSB (DNA double-strand breaks) levels in both DSS-induced colitis and TNF-treated colonial cell models . This genome-stabilizing effect may be partially dependent on fmt function through the expression of proteins involved in host DNA repair pathway activation, such as APC7.

What methodologies are most effective for studying fmt mutations in B. infantis?

Studying fmt mutations in B. infantis presents unique challenges due to the essential nature of this enzyme and the specific genetic characteristics of Bifidobacterium species. The most effective methodologies include:

1. CRISPR-Cas9 Based Approaches:

  • Design sgRNAs targeting specific regions of the fmt gene

  • Use a Bifidobacterium-optimized CRISPR-Cas9 system with appropriate promoters

  • Engineer point mutations rather than complete knockouts due to the likely essential nature of fmt

  • Deliver via electroporation with methylation-pattern matching to avoid restriction barriers

2. Complementation Studies:

  • Express wild-type or mutant fmt variants in trans

  • Use inducible promoters (e.g., xylose-inducible system) to control expression levels

  • Measure growth kinetics, protein synthesis rates, and metabolic activities

3. Chemical Mutagenesis and Screening:

  • Use EMS or UV mutagenesis followed by selection for fmt mutations with partial function

  • Screen for temperature-sensitive or substrate-specificity mutants

  • Sequence recovered mutants to identify critical residues

4. Functional Assays for fmt Activity Assessment:

Assay TypeMethodologyParameters MeasuredAdvantages
In vitro formylationPurified enzyme with Met-tRNAᴹᵉᵗ substrateFormylation rate, substrate affinityDirect measurement of enzymatic activity
Pulse-chase labeling³⁵S-methionine incorporationProtein synthesis ratesMeasures impact on translation in vivo
Ribosome profilingNGS of ribosome-protected fragmentsTranslation efficiency genome-wideIdentifies specific mRNAs affected
ProteomicsLC-MS/MSProtein abundance changesComprehensive view of proteome impact
Metabolic labeling¹⁵N-urea tracingNitrogen incorporation patternsConnects to specialized nitrogen metabolism

5. Structural Studies:

  • X-ray crystallography or cryo-EM of wild-type and mutant proteins

  • Molecular dynamics simulations to predict effects of mutations

  • Structure-guided design of selective inhibitors for in vivo studies

When investigating fmt mutations, it's important to consider the unique metabolic context of B. infantis, including its specialized pathways for HMO utilization and urea nitrogen recycling , which may be particularly sensitive to alterations in translation initiation efficiency.

How does B. infantis fmt interact with the specialized metabolic pathways for human milk oligosaccharide (HMO) utilization?

B. infantis possesses an extensive genomic region dedicated to HMO utilization, containing genes for specialized transport systems (solute-binding proteins and ATP-binding cassette transporters) and glycosidases (α-sialidases, α-fucosidases, β-hexosaminadases, and β-galactosidases) . The fmt enzyme likely plays a critical role in the expression of this specialized metabolic machinery through:

  • Coordinated translation of HMO utilization gene clusters: The efficient expression of these gene clusters during exposure to HMOs requires robust translation initiation mediated by fmt.

  • Metabolic adaptation: When B. infantis shifts from one carbon source to HMOs, rapid proteome remodeling is necessary, requiring efficient translation of new enzymes.

  • Energy allocation: HMO metabolism provides B. infantis with a competitive advantage, allowing it to achieve cell densities three times higher than other Bifidobacterium species . This rapid growth requires efficient protein synthesis.

Experimental approaches to study this interaction:

  • Analyze translation efficiency of HMO utilization genes under varying fmt activity levels

  • Compare growth rates on HMOs with wild-type vs. fmt-modulated strains

  • Measure enzymatic activities of key HMO-processing enzymes with altered fmt expression

  • Perform competition assays between fmt variants in HMO-containing media

The specialized ATP-binding cassette (ABC) transporters that B. infantis uses for HMO import represent a significant energy investment for the cell, and their expression likely receives translational priority through fmt-mediated mechanisms.

What role does fmt play in B. infantis' genome stability maintenance properties?

Recent research has demonstrated that B. infantis helps maintain genome stability in ulcerative colitis models by reducing DNA double-strand breaks (DSBs) . The fmt enzyme may contribute to this protective effect through several mechanisms:

  • Expression of protective factors: B. infantis has been shown to upregulate anaphase-promoting complex subunit 7 (APC7) in host cells, which activates DNA repair pathways . The efficient translation of bacterial factors that signal to host cells depends on fmt activity.

  • Metabolite production: The production of protective metabolites by B. infantis that help maintain host genome stability requires efficient bacterial protein synthesis.

  • Stress response: Under inflammatory conditions, B. infantis must adapt its proteome to survive while maintaining its protective functions, a process dependent on efficient translation initiation.

Methodological approaches for investigation:

  • Compare the ability of wild-type vs. fmt-modulated B. infantis strains to reduce DSBs in TNFα-induced colonial cell models

  • Analyze secretome composition with varying fmt activity levels

  • Measure expression of host DNA repair genes in response to supernatants from fmt-variant strains

  • Identify bacterial proteins involved in host cell signaling using crosslinking approaches

Table: Impact of B. infantis fmt on Host Cell DNA Stability Markers

fmt StatusDSB Reduction (%)APC7 InductionHost DNA Repair Pathway ActivationInflammatory Marker Reduction
Wild-type65-80+++HighSignificant
Overexpression70-85++++EnhancedModerate increase
Partial depletion30-45+ReducedMinimal
Control (no bacteria)0-BaselineNone

Note: This table represents hypothesized relationships based on current understanding of B. infantis genome stabilizing properties .

What are the main challenges in purifying active recombinant B. infantis fmt and how can they be addressed?

Purifying active recombinant B. infantis fmt presents several technical challenges that require specific strategies to overcome:

Challenge 1: Protein Solubility

  • Issue: B. infantis fmt may form inclusion bodies when overexpressed in E. coli

  • Solution:

    • Lower expression temperature (16-20°C)

    • Use solubility-enhancing tags (MBP, SUMO)

    • Express in specialized E. coli strains (Arctic Express, Rosetta-gami)

    • Add osmolytes (glycerol, sorbitol) to lysis buffer

Challenge 2: Enzyme Stability

  • Issue: Fmt may lose activity rapidly after purification

  • Solution:

    • Include stabilizing agents (glycerol 10-20%, reducing agents)

    • Minimize freeze-thaw cycles

    • Optimize buffer composition based on thermal shift assays

    • Consider protein engineering to enhance stability

Challenge 3: Cofactor Requirements

  • Issue: Maintaining association with essential cofactors

  • Solution:

    • Include 10-formyltetrahydrofolate in purification buffers

    • Reconstitute activity with excess cofactor after purification

    • Optimize metal ion concentrations (Mg²⁺, Mn²⁺)

Purification Protocol Optimization Table:

StepCritical ParametersTroubleshootingQuality Control
Cell lysisBuffer pH 7.0-7.5, protease inhibitors, gentle disruptionInclusion bodies: add detergents (0.1% Triton X-100)SDS-PAGE to check soluble fraction
Affinity chromatographyFlow rate: 0.5-1 ml/min, imidazole gradientNon-specific binding: increase wash stringencyActivity assay after each step
Tag removalProtease:protein ratio, digestion timeIncomplete cleavage: optimize conditionsSDS-PAGE to confirm cleavage
Size exclusionBuffer composition, flow rateAggregation: add stabilizing agentsDynamic light scattering for homogeneity
StorageGlycerol concentration, temperatureActivity loss: test cryoprotectantsRepeated activity tests over time

Methodology for activity validation:

  • In vitro formylation assay using purified Met-tRNAᴹᵉᵗ

  • Circular dichroism to confirm proper folding

  • Thermal shift assays to optimize stabilizing conditions

  • Mass spectrometry to confirm correct processing and modifications

How can researchers accurately measure fmt activity in B. infantis during growth on different carbon and nitrogen sources?

Measuring fmt activity accurately during bacterial growth on different substrates requires methods that account for B. infantis' specialized metabolism, particularly its unique pathways for HMO utilization and urea nitrogen recycling :

1. Gene Expression Analysis:

  • qRT-PCR targeting fmt mRNA

  • RNA-seq for global context of fmt expression

  • Ribosome profiling to assess translation efficiency

2. Protein-Level Analysis:

  • Western blotting with fmt-specific antibodies

  • Targeted proteomics (SRM/MRM) for absolute quantification

  • Activity-based protein profiling with fmt-specific probes

3. Functional Activity Assays:

Assay TypeMethodologyAdvantagesLimitations
Whole-cell assayMeasure incorporation of labeled methioninePhysiologically relevantIndirect measure
Cell extract assayFormylation of exogenous Met-tRNAᴹᵉᵗControls substrate availabilityPotential loss of cellular context
In vivo reporterN-terminal formylation-dependent reporterReal-time monitoringEngineering challenges
Metabolic labelingTrace formylated peptides via mass spectrometryDirect measurement of productsTechnical complexity

4. Experimental Design Considerations:

  • Compare defined media with different carbon sources (glucose, HMOs, lactose)

  • Test nitrogen source variations (peptides, amino acids, urea)

  • Sample at multiple growth phases (lag, exponential, stationary)

  • Include strain variants (reference ATCC 15697, clinical isolates)

When B. infantis grows on urea as a nitrogen source, it demonstrates altered central metabolism with increased formate:lactate and ethanol:acetate ratios , which may reflect changes in translational efficiency mediated by fmt activity. Similarly, growth on HMOs induces a specific metabolic program that likely has distinct fmt activity requirements.

What are the implications of fmt function for developing improved B. infantis strains for research applications?

Understanding fmt function in B. infantis can inform the development of improved strains for various research applications:

Enhanced Expression Systems

  • Engineering optimized translation initiation regions compatible with fmt

  • Developing inducible expression systems based on fmt modulation

  • Creating strains with tunable protein synthesis rates for metabolic engineering

Improved Colonization Models

  • Designing strains with enhanced colonization through optimized fmt function

  • Creating reporter strains to monitor translation efficiency in vivo

  • Engineering competitive fitness advantages for microbiome studies

Specialized Research Tools

Applicationfmt-Related EnhancementBenefit for Research
Metabolic pathway probingControlled expression of metabolic enzymesStudy HMO and urea utilization mechanisms
Host-microbe interaction modelsOptimized expression of surface proteinsInvestigate immunomodulatory properties
Protein production systemsEnhanced translation efficiencyProduce difficult-to-express proteins
Genome stability studiesControlled production of DNA repair factorsStudy mechanisms of host genome protection

4. Methodological Considerations:

  • Use genome editing to introduce specific fmt variants

  • Engineer regulatory elements controlling fmt expression

  • Develop conditional fmt systems responsive to environmental signals

  • Create fmt-dependent reporter systems for in vivo studies

The specialized nitrogen metabolism of B. infantis, which can incorporate urea nitrogen into its proteome , represents a unique feature that could be enhanced through fmt engineering for specialized applications in nitrogen-limited environments.

What emerging technologies could advance our understanding of B. infantis fmt function in infant gut colonization?

Several cutting-edge technologies hold promise for elucidating the role of fmt in B. infantis colonization of the infant gut:

1. Single-Cell Approaches:

  • Single-cell RNA-seq to capture fmt expression heterogeneity during colonization

  • Spatial transcriptomics to map fmt activity across gut niches

  • Single-cell proteomics to detect cell-to-cell variation in translation efficiency

2. Advanced In Vivo Imaging:

  • Fluorescent translational reporters linked to fmt activity

  • Intravital microscopy to visualize colonization dynamics

  • Biomolecular fluorescence complementation to detect fmt interactions in vivo

3. Systems Biology Integration:

TechnologyApplication to fmt ResearchExpected Insights
Multi-omics integrationCombine transcriptomics, proteomics, and metabolomics dataHolistic view of fmt's role in metabolic networks
Genome-scale modelsIncorporate translation initiation parametersPredict impact of fmt on global metabolism
Network analysisMap fmt-dependent protein interaction networksIdentify key nodes in colonization processes
Machine learningPredict fmt activity based on environmental parametersDevelop predictive models of colonization success

4. Engineered Model Systems:

  • Humanized gnotobiotic models with defined microbiomes

  • Organ-on-chip systems modeling the infant gut environment

  • CRISPR-based screening to identify fmt-dependent colonization factors

The unique ability of B. infantis to dominate the infant gut microbiome (up to 80% in breastfed infants with B. infantis EVC001) suggests that its protein synthesis machinery, including fmt, is highly adapted to this specialized niche. New technologies that can capture the spatial and temporal dynamics of fmt activity during colonization will be particularly valuable.

How might fmt function connect to B. infantis' role in early life immune development?

B. infantis plays a significant role in early immune development, enhancing the synthesis of anti-inflammatory cytokines like IL-10 and potentially protecting against conditions like ulcerative colitis through genome stability maintenance . The fmt enzyme may connect to these immunomodulatory properties through several mechanisms:

1. Translation of Immunoactive Factors:

  • The efficient translation of bacterial proteins that interact with host immune cells requires fmt

  • Expression of factors that upregulate host APC7 may depend on optimal fmt function

  • Production of immunomodulatory metabolites requires efficient protein synthesis

2. Adaptation to Host Immune Environment:

  • Rapid proteome remodeling in response to host immune factors

  • Translation of stress response proteins during immune challenge

  • Production of defensive factors against host antimicrobial peptides

3. Research Approaches to Investigate This Connection:

MethodologyExperimental DesignExpected OutcomesRelevance to Immune Development
Immune cell co-cultureCompare wild-type vs. fmt variants with dendritic cellsCytokine profile differencesDirect impact on immune programming
Gnotobiotic modelsColonize germ-free mice with fmt variantsImmune tissue development changesDevelopmental programming effects
Transcriptional profilingHost cell response to bacterial supernatantsDifferential immune pathway activationSecreted factor identification
MetabolomicsCompare metabolites from fmt variantsAltered immunomodulatory compoundsIndirect impact mechanisms
ProteomicsSurface proteome analysisChanges in immunoactive proteinsDirect interaction mediators

4. Potential Mechanisms with Clinical Relevance:

  • Fmt-dependent expression of factors that reduce DNA double-strand breaks in host cells

  • Translation of proteins involved in maintenance of intestinal barrier function

  • Production of SCFAs that regulate immune development through fmt-dependent metabolic pathways

The ability of B. infantis to alter the fecal pH (to approximately 5.15) and reduce fecal endotoxins likely depends on efficient translation of metabolic enzymes and defense factors, making fmt a potential key regulator of these protective effects.

How does B. infantis fmt differ from homologs in other bacterial species in terms of structure and function?

Methionyl-tRNA formyltransferase (fmt) is conserved across bacterial species, but B. infantis fmt likely possesses unique features adapted to its specialized ecological niche:

1. Structural Comparisons:

FeatureB. infantis fmtE. coli fmtOther Bifidobacteria fmt
Active site architectureLikely optimized for function at lower pHStandard bacterial organizationSpecies-specific variations
Substrate binding pocketPotentially adapted for efficient function with B. infantis initiator tRNAWell-characterized canonical structureVariations correlating with ecological niche
Regulatory domainsMay contain unique regulatory elementsStandard bacterial organizationLimited variation within genus
Protein dynamicsPotentially adapted for activity in acidic gut environmentOptimal at neutral pHSpecies-specific adaptations

2. Functional Distinctions:

  • B. infantis fmt may function optimally at the lower pH created by its fermentative metabolism (pH ~5.15)

  • The enzyme may have evolved for efficient activity under the nitrogen-limited conditions of the infant gut

  • Potential adaptation for optimal function during rapid growth on HMOs

3. Methodological Approaches for Comparative Analysis:

  • Homology modeling based on solved bacterial fmt structures

  • Site-directed mutagenesis of potentially unique residues

  • Heterologous expression and cross-species complementation

  • Biochemical characterization under varying conditions (pH, temperature, substrate availability)

4. Evolutionary Context:

  • Phylogenetic analysis to trace fmt evolution in Bifidobacterium lineages

  • Correlation with host adaptation (human infant-adapted vs. other niches)

  • Assessment of selective pressure on fmt coding sequences

The specialized nitrogen metabolism of B. infantis, particularly its ability to utilize urea nitrogen and incorporate it into its proteome , suggests potential unique adaptations in its translation machinery, including the fmt enzyme, to efficiently utilize available nitrogen sources in the infant gut environment.

What insights can be gained from studying fmt across different B. infantis strains with varying HMO utilization capabilities?

Different B. infantis strains show variations in their ability to utilize HMOs, with some strains like UMA299 being less efficient at HMO metabolism . Studying fmt across these strains can provide valuable insights:

1. Correlation Analysis:

B. infantis StrainHMO UtilizationFmt CharacteristicsColonization EfficiencyUrea Utilization
ATCC 15697 (Reference)EfficientBaseline for comparisonHighEfficient
UMA272EfficientSimilar growth rate on urea/complex NHighEfficient
UMA299Less efficientSlower growth rate on ureaReducedLess efficient
UMA302EfficientVigorous growth on ureaHighHighly efficient
EVC001Highly efficientNot directly characterizedVery high (80% dominance)Not characterized

2. Research Questions to Address:

  • Does fmt expression or activity correlate with HMO utilization efficiency?

  • Are there sequence variations in fmt across strains with different metabolic capabilities?

  • How does translation efficiency of HMO utilization genes vary across strains?

  • Is fmt differentially regulated in response to HMOs in different strains?

3. Methodological Approaches:

  • Comparative genomics of fmt and associated translation factors

  • Transcriptional and translational profiling during growth on HMOs

  • Recombinant expression and biochemical characterization of fmt variants

  • Cross-complementation studies between strains

4. Potential Insights:

  • Identification of fmt sequence features that correlate with efficient HMO utilization

  • Understanding regulatory networks linking carbon source to translation initiation

  • Discovery of strain-specific translation optimization strategies

  • Development of biomarkers for predicting colonization potential

The strain UMA299, which does not efficiently metabolize HMOs and shows a significantly lower growth rate on urea compared to other B. infantis isolates , represents a valuable comparative model for understanding how fmt function may relate to these specialized metabolic capabilities.

What are the most effective approaches for analyzing the impact of fmt on the B. infantis proteome?

Analyzing how fmt affects the B. infantis proteome requires a multi-faceted approach that captures both global and specific effects on protein synthesis:

1. Global Proteome Analysis:

MethodologyKey ApplicationsTechnical ConsiderationsData Analysis Approach
Shotgun proteomics (LC-MS/MS)Comprehensive protein identificationSample preparation critical for membrane proteinsStatistical comparison across conditions
SILAC or TMT labelingQuantitative comparison between fmt variantsRequires metabolic labeling or chemical taggingRatio-based quantification
N-terminal proteomicsSpecific analysis of translation initiationEnrichment of N-terminal peptidesFocus on formylated vs. unformylated initiator Met
Ribosome profilingTranslation efficiency genome-wideRNA isolation and footprinting qualityDifferential translation analysis

2. Targeted Approaches:

  • Parallel reaction monitoring (PRM) for key proteins in HMO utilization pathways

  • Selected reaction monitoring (SRM) for quantitative analysis of fmt itself

  • Pulse-chase experiments with labeled amino acids to measure synthesis rates

  • Polysome profiling to assess translation efficiency of specific mRNAs

3. Specialized Analyses for fmt Function:

  • ¹⁵N-urea labeling to track nitrogen incorporation into proteins

  • Analysis of N-terminal modifications (formylation status)

  • Identification of proteins differentially translated under fmt modulation

  • Assessment of post-translational modifications dependent on translation initiation

4. Integrated Analysis Framework:

  • Correlate proteome changes with transcriptional profiles

  • Map affected proteins to metabolic pathways (especially HMO utilization and nitrogen metabolism)

  • Identify regulatory networks affected by altered fmt activity

  • Connect proteome changes to phenotypic outcomes (growth, colonization)

The ability of B. infantis to incorporate urea nitrogen into 234 proteins in its proteome provides a unique opportunity to study how fmt impacts nitrogen flow through protein synthesis pathways, particularly in the context of its specialized adaptation to the infant gut environment.

What are the critical knowledge gaps in our understanding of B. infantis fmt and its biological significance?

Despite advances in understanding B. infantis biology, several critical knowledge gaps remain regarding its fmt enzyme:

1. Structural and Biochemical Characterization:

  • Three-dimensional structure of B. infantis fmt remains unsolved

  • Kinetic parameters specific to B. infantis fmt are undetermined

  • Regulatory mechanisms controlling fmt expression are poorly understood

  • Post-translational modifications affecting fmt activity are unexplored

2. Physiological Role:

  • Connection between fmt activity and specialized metabolic pathways (HMO utilization, urea nitrogen recycling)

  • Impact of fmt on protein synthesis during different growth phases

  • Role in adaptation to the specific environment of the infant gut

  • Influence on competitive fitness against other gut microbes

3. Host Interaction Effects:

  • How fmt-dependent protein synthesis affects immunomodulatory properties

  • Role in producing factors that maintain host genome stability

  • Connection to B. infantis' protective effects against inflammatory conditions

  • Impact on production of metabolites affecting host development

4. Evolutionary Context:

  • Selective pressures that have shaped B. infantis fmt

  • Comparison with fmt from bacteria adapted to different niches

  • Horizontal gene transfer events affecting fmt and associated factors

  • Co-evolution with human milk components

Addressing these knowledge gaps will require integrative approaches combining structural biology, biochemistry, molecular genetics, systems biology, and host-microbe interaction studies.

What interdisciplinary approaches might yield breakthrough insights about B. infantis fmt function?

Breakthrough insights about B. infantis fmt function will likely emerge from interdisciplinary approaches that bridge multiple scientific domains:

1. Integration of Structural Biology and Systems Biology:

  • Combining atomic-resolution structures with global proteome analysis

  • Mapping fmt interactions within the entire translation initiation complex

  • Modeling how fmt structure relates to function in different environments

  • Predicting impacts of structural variations on metabolic network performance

2. Developmental Biology and Microbiology Interface:

  • Studying how fmt-dependent processes in B. infantis influence infant development

  • Connecting bacterial protein synthesis to host developmental trajectories

  • Examining transgenerational effects of B. infantis colonization

  • Analyzing host-microbe co-development through the lens of translation

3. Clinical and Basic Science Convergence:

Clinical ObservationBasic Science QuestionInterdisciplinary ApproachPotential Insight
B. infantis colonization correlates with reduced inflammatory markersHow does fmt affect production of anti-inflammatory factors?Combine clinical samples with mechanistic studiesIdentify specific fmt-dependent protective mechanisms
Genome stability maintenance in ulcerative colitisWhat B. infantis proteins mediate APC7 upregulation?Integrate clinical genomics with bacterial geneticsDiscover fmt-dependent protective factors
Metabolic benefits of B. infantis colonizationHow does fmt affect the bacterial metabolome?Combine metabolomics with translational analysisIdentify key metabolic nodes dependent on fmt
Developmental outcomes in colonized infantsWhich developmental pathways respond to B. infantis?Developmental biology + microbiologyDiscover mechanisms of developmental programming

4. Computational and Experimental Synthesis:

  • Machine learning to predict fmt activity based on environmental parameters

  • Multi-scale modeling from molecular dynamics to ecological interactions

  • Network inference to position fmt within global regulatory networks

  • Genome-scale models incorporating translation initiation parameters

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.